These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 37515373)
1. A systematic pipeline of protein structure selection for computer-aided drug discovery: A case study on T790M/L858R mutant EGFR structures. Das AP; Nandekar P; Mathur P; Agarwal SM Protein Sci; 2023 Sep; 32(9):e4740. PubMed ID: 37515373 [TBL] [Abstract][Full Text] [Related]
3. Inhibiting two cellular mutant epidermal growth factor receptor tyrosine kinases by addressing computationally assessed crystal ligand pockets. Lee JH; Lin WC; Wen TK; Wang C; Lin YT Future Med Chem; 2019 Apr; 11(8):833-846. PubMed ID: 30724109 [No Abstract] [Full Text] [Related]
4. Computational identification of new TKI as potential noncovalent reversible EGFR Abdelmalek D; Smaoui F; Frikha F; Ben Marzoug R; Msalbi D; Souissi A; Aifa MS J Biomol Struct Dyn; 2024 Jun; 42(9):4870-4887. PubMed ID: 37349947 [TBL] [Abstract][Full Text] [Related]
5. Computational and Synthetic approach with Biological Evaluation of Substituted Quinoline derivatives as small molecule L858R/T790M/C797S triple mutant EGFR inhibitors targeting resistance in Non-Small Cell Lung Cancer (NSCLC). Karnik KS; Sarkate AP; Tiwari SV; Azad R; Burra PVLS; Wakte PS Bioorg Chem; 2021 Feb; 107():104612. PubMed ID: 33476869 [TBL] [Abstract][Full Text] [Related]
6. Molecular docking of novel 5-O-benzoylpinostrobin derivatives as wild type and L858R/T790M/V948R mutant EGFR inhibitor. Pratama MRF; Poerwono H; Siswodihardjo S J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31855568 [TBL] [Abstract][Full Text] [Related]
7. Rational Computational Design of Fourth-Generation EGFR Inhibitors to Combat Drug-Resistant Non-Small Cell Lung Cancer. Park H; Jung HY; Kim K; Kim M; Hong S Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297461 [TBL] [Abstract][Full Text] [Related]
8. Discovery of the allosteric inhibitor from actinomyces metabolites to target EGFR Saini R; Kumari S; Bhatnagar A; Singh A; Mishra A Sci Rep; 2023 Jun; 13(1):8885. PubMed ID: 37264083 [TBL] [Abstract][Full Text] [Related]
9. Identification of small-molecule EGFR allosteric inhibitors by high-throughput docking. Caporuscio F; Tinivella A; Restelli V; Semrau MS; Pinzi L; Storici P; Broggini M; Rastelli G Future Med Chem; 2018 Jul; 10(13):1545-1553. PubMed ID: 29766737 [TBL] [Abstract][Full Text] [Related]
10. Molecular Docking Optimization in the Context of Multi-Drug Resistant and Sensitive EGFR Mutants. García-Godoy MJ; López-Camacho E; García-Nieto J; Nebro AJ; Aldana-Montes JF Molecules; 2016 Nov; 21(11):. PubMed ID: 27869781 [TBL] [Abstract][Full Text] [Related]
11. Quinoxalinones as A Novel Inhibitor Scaffold for EGFR (L858R/T790M/C797S) Tyrosine Kinase: Molecular Docking, Biological Evaluations, and Computational Insights. Suriya U; Mahalapbutr P; Wimonsong W; Yotphan S; Choowongkomon K; Rungrotmongkol T Molecules; 2022 Dec; 27(24):. PubMed ID: 36558033 [TBL] [Abstract][Full Text] [Related]